[1] RAJALINGAM K, DIKIC I. SnapShot: expanding the ubiquitin code[J]. Cell, 2016, 164(5): 1074-1074. doi:  10.1016/j.cell.2016.02.019
[2] DEBNATH J, GAMMOH N, RYAN K M. Autophagy and autophagy-related pathways in cancer[J]. Nat Rev Mol Cell Biol, 2023, 24(8): 560-575. doi:  10.1038/s41580-023-00585-z
[3] MATSUZAWA-ISHIMOTO Y, HWANG S, CADWELL K. Autophagy and inflammation[J]. Annu Rev Immunol, 2018, 36: 73-101. doi:  10.1146/annurev-immunol-042617-053253
[4] DEWSON G, EICHHORN P J A, KOMANDER D. Deubiquitinases in cancer[J]. Nat Rev Cancer, 2023, 23(12): 842-862. doi:  10.1038/s41568-023-00633-y
[5] KWON Y T, CIECHANOVER A. The ubiquitin code in the ubiquitin-proteasome system and autophagy[J]. Trends Biochem Sci, 2017, 42(11): 873-886. doi:  10.1016/j.tibs.2017.09.002
[6] Kemp S B, Cheng N, Markosyan N, et al. Efficacy of a small-molecule inhibitor of KrasG12D in immunocompetent models of pancreatic cancer[J]. Cancer Discov, 2023, 13(2): 298-311. doi:  10.1158/2159-8290.CD-22-1066
[7] YAU R, RAPE M. The increasing complexity of the ubiquitin code[J]. Nat Cell Biol, 2016, 18(6): 579-586. doi:  10.1038/ncb3358
[8] ZHANG Y, FU Y S, QIANG L H, et al. Spatiotemporal regulation of STING activity by linear ubiquitination governs antiviral immunity[J]. Adv Sci, 2025, 12(28): 2417660. doi:  10.1002/advs.202417660
[9] ZEIN L, DIETRICH M, BALTA D, et al. Linear ubiquitination at damaged lysosomes induces local NFKB activation and controls cell survival[J]. Autophagy, 2025, 21(5): 1075-1095. doi:  10.1080/15548627.2024.2443945
[10] WIENER R, WOLBERGER C. A new DUB makes linear ubiquitin a party to its own destruction[J]. Cell, 2013, 153(6): 1189-1191. doi:  10.1016/j.cell.2013.05.018
[11] WANG W, LI M Q, PONNUSAMY S, et al. ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt/β-catenin activation to enhance drug resistance in breast cancers[J]. Nat Commun, 2020, 11(1): 3965. doi:  10.1038/s41467-020-17770-9
[12] HRDINKA M, GYRD-HANSEN M. The Met1-linked ubiquitin machinery: emerging themes of(de)regulation[J]. Mol Cell, 2017, 68(2): 265-280. doi:  10.1016/j.molcel.2017.09.001
[13] JAHAN A S, ELBÆK C R, DAMGAARD R B. Met1-linked ubiquitin signalling in health and disease: inflammation, immunity, cancer, and beyond[J]. Cell Death Differ, 2021, 28(2): 473-492. doi:  10.1038/s41418-020-00676-w
[14] HEGER K, WICKLIFFE K E, NDOJA A, et al. OTULIN limits cell death and inflammation by deubiquitinating LUBAC[J]. Nature, 2018, 559(7712): 120-124. doi:  10.1038/s41586-018-0256-2
[15] KEUSEKOTTEN K, ELLIOTT P R, GLOCKNER L, et al. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin[J]. Cell, 2013, 153(6): 1312-1326. doi:  10.1016/j.cell.2013.05.014
[16] CHEN Y F, WANG L F, CHENG X M, et al. An ultrasensitive system for measuring the USPs and OTULIN activity using Nanoluc as a reporter[J]. Biochem Biophys Res Commun, 2014, 455(3-4): 178-183. doi:  10.1016/j.bbrc.2014.10.139
[17] ALTUN M, KRAMER H B, WILLEMS L I, et al. Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes[J]. Chem Biol, 2011, 18(11): 1401-1412. doi:  10.1016/j.chembiol.2011.08.018
[18] ZHOU Q, YU X M, DEMIRKAYA E, et al. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease[J]. Proc Natl Acad Sci USA, 2016, 113(36): 10127-10132. doi:  10.1073/pnas.1612594113